Tier 1 — highest
The study of bioavailability and endogenous circadian rhythm of menaquinone-7, a form of vitamin K2, in healthy subjects
The British journal of nutrition
2023
130(11):1885-1897
Bibliography
- PubMed
- PMID 37132123
- Funding
- Funding is not specified in the indexed abstract or accessible funding metadata. Consult the original publication for the declaration.
- Competing interests
- A competing-interest declaration is not available in the indexed abstract or accessible disclosure metadata.
Study snapshot
| Design | Randomized controlled clinical trial |
|---|---|
| Model | Human participants |
| Sample | Two pharmacokinetic studies involving 5 and 12 healthy men |
| Intervention | Single fasting MK-7 dose of 1 mg |
| Duration | Single-dose pharmacokinetic monitoring |
| Endpoints | Plasma MK-7 concentrations; Absorption and elimination; Circadian variation |
What the study showed, in plain terms
Key findings
What this study can and cannot tell us
Editorial review
Reviewed by the Biohack Blueprint research team
Last verified
Biohack Blueprint Research
